Assessment of Patient Experience During Treatment for Cancer

Carcinoma Clinical Trial

Official title:

Assessment of Patient Experience During Treatment for Cancer

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT01553825
• Other study ID #: IRB-22490
• Secondary ID: SU-03082012-9290
• Status: Completed
• Start date: March 2012
• Est. completion date: January 9, 2020

Study information

• Verified date: April 2019
• Source: Stanford University
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

Assessing the mindset of cancer patients will help us better understand which patients are having difficulty dealing with the diagnosis and treatment that may not otherwise be fully appreciated by their physicians. By identifying such patients, we may then be able to design and implement strategies that can help improve their coping skills both during the treatment as well as after the completion of treatment. In addition to addressing physical concerns and symptoms, this approach will help address the overall emotional impact of a cancer diagnosis as more patients are living as cancer survivors.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 116
• Est. completion date: January 9, 2020
• Est. primary completion date: June 30, 2019
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Pathologically diagnosed carcinoma patients at Stanford cancer center who signed the informed consent form.

Exclusion Criteria:

• Patients with a prognosis of < 6 months life expectancy

Related Conditions & MeSH terms

• Carcinoma

Locations

Country	Name	City	State
United States	Stanford University, School of Medicine	Palo Alto	California

Sponsors (1)

Lead Sponsor	Collaborator
Stanford University

Country where clinical trial is conducted

United States,